Fiorino Anthony S. 4
4 · IMMUNE PHARMACEUTICALS INC · Filed Sep 18, 2017
Insider Transaction Report
Form 4
Fiorino Anthony S.
Chief Medical Officer and COO
Transactions
- Award
Stock Option
2017-09-14+90,000→ 90,000 totalExercise: $1.10From: 2017-09-14Exp: 2027-09-14→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]15% of the options shall vest ninety (90) days following the date of grant; 15% on the first-year anniversary of the date of grant (the "Anniversary") and 70% in equal portions at the end of each three (3) month period over the course of a two (2) year period commencing on the Anniversary.